Glenmark Pharmaceuticals Limited — Updates, 09-04-2026: Press Release
09-04-2026 | 08:50 am
09-04-2026 | 08:50 am
Glenmark received US FDA approval for Progesterone Vaginal Inserts, 100 mg. This opens access to a US market with ~$59.2 million (approx. 491 Cr) in annual sales for the reference product, boosting Glenmark's women's healthcare focus.
No comments yet. Be the first to comment!
